Yıl: 2022 Cilt: 28 Sayı: 6 Sayfa Aralığı: 743 - 750 Metin Dili: İngilizce DOI: 10.14744/tjtes.2021.04134 İndeks Tarihi: 07-11-2022

Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study

Öz:
BACKGROUND: The most common cause of intra-abdominal adhesion (IAA) is previous abdominal surgery and mortality. IAA can cause serious complications such as chronic abdominal pain, ileus, and infertility. Approximately 3% of all laparotomies are related to adhesions. IAA reduces the quality of life of the patient, causes morbidity, and increases health expenditures. In this study, we aimed to investigate the preventive effect of fucoxanthin (Fx) on IAA in the intra-abdominal surgical adhesion model that experimentally created in rats. METHODS: This study used 21 Sprague-Dawley rats divided into three groups. After anesthesia, the abdomen was opened, the cecum and right abdominal wall were damaged with a sterile toothbrush until petechiae bleeding was seen. No additional action was taken to the control group. In the sham group, 5 cc saline solution was released into the peritoneum before the abdomen was closed. In the Fx group, 35 mg/kg Fx was instilled intraperitoneally and the abdomen was closed. On the 21 st post-operative day, all subjects were anesthetized with standard anesthesia. Macroscopic adhesions were quantitatively evaluated according to the Mazuji classifica- tion. The cecum anterior wall and parietal peritoneum were excised for pathological sampling. A pathologist, unaware of the groups, evaluated inflammation, fibroblastic activity, and vascular proliferation. In addition, serum tumor necrosis factor-alpha (TNF-α) and interleukin-10 levels were measured. RESULTS: No rat was lost during the study period. Congenital adhesion was not observed in any of the subjects at the first laparo- tomy. Adhesion was significantly less macroscopically in the Fx group compared to the control and sham group (p<0.001 and p<0.001). Fibroblastic activity was found to be significantly less in the Fx group compared to the sham and control groups (p<0.001 and p<0.001). Vascular proliferation was found to be significantly less in the Fx group than in the sham and control groups (p<0.001 and p<0.001). The inflammation score was significantly lower in the Fx group compared to the other two groups (p<0.001 and p<0.001). The inflam- mation score in the sham group was lower than the control group and was statistically significant (p<0.001). TNF-α level was found to be statistically significantly lower in the Fx group compared to the sham and control groups (p<0.001 and p<0.001). CONCLUSION: As a result of experimental study, we can say that Fx is effective in preventing IAAs and decreases the level of TNF-α, a pro-inflammatory cytokine.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
  • 1. Beyene RT, Kavalukas SL, Barbul A. Intra-abdominal adhesions: Anatomy, physiology, pathophysiology, and treatment. Curr Probl Surg 2015;52:271–319.
  • 2. Holmdahl L, Ericsson E, Ericsson BI, Risberg B. Depression of peri- toneal fibrinolysis during operation is a local response to trauma. Surgery 1998;13:539–44.
  • 3. Moris D, Chakedis J, Rahnemai-Azar AA, Wilson A, Hennessy MM, Athanasiou A, et al. Postoperative abdominal adhesions: Clinical signif- icance and advances in prevention and management. J Gastrointest Surg 2017;21:1713–22.
  • 4. Ward BC, Panitch A. Abdominal adhesions: Current and novel therapies. J Surg Res 2011;165:91–111.
  • 5. Wallwiener M, Brucker S, Hierlemann H, Brochhausen C, Solomayer E, Wallwiener C. Innovative barriers for peritoneal adhesion prevention: Liquid or solid? A rat uterine horn model. Fertil Steril 2006;86 Suppl 4:1266–76.
  • 6. Trew G. Postoperative adhesions and their prevention. Rev Gynaecol Perinat Pract 2006;6:47–56.
  • 7. Satomi Y. Antitumor and cancer-preventative function of fucoxanthin: A marine carotenoid. Anticancer Res 2017;37:1557–62.
  • 8. Arumugam V, Venkatesan M, Ramachandran S, Sundaresan U. Bioactive peptides from marine ascidians and future drug development-A review. Int J Pept Res Ther 2017;24:13–18.
  • 9. Altınel Y, Taşpınar E, Ozgüç H, Oztürk E, Akyıldız EU, Bağdaş D. The protective effect of clinoleic against post-surgical adhesions. Ulus Travma Acil Cerrahi Derg 2014;20:16.
  • 10. Yan S, Yue Y, Zeng L, Jiang C, Li W, Li H, et al. Ligustrazine nanopar- ticles nano spray’s activation on Nrf2/ARE pathway in oxidative stress injury in rats with postoperative abdominal adhesion. Ann Transl Med 2019;7:379.
  • 11. Lu S, Hu W, Zhang Z, Ji Z, Zhang T. Sirolimus-coated, poly(L-lactic acid)-modified polypropylene mesh with minimal intra-peritoneal adhe- sion formation in a rat model. Hernia 2018;22:1051–60.
  • 12. Liu M, Li W, Chen Y, Wan X, Wang J. Fucoxanthin: A promis- ing compound for human inflammation-related diseases. Life Sci 2020;255:117850.
  • 13. Wang J, Ma Y, Yang J, Jin L, Gao Z, Xue L, et al. Fucoxanthin inhibits tu- mour-related lymphangiogenesis and growth of breast cancer. J Cell Mol Med 2019;23:2219–29.
  • 14. Maeda H, Kanno S, Kodate M, Hosokawa M, Miyashita K. Fucoxanthi- nol, metabolite of fucoxanthin, ımproves obesity-ınduced ınflammation in adipocyte cells. Mar Drugs 2015;13:4799–813.
  • 15. Zheng J, Tian X, Zhang W, Zheng P, Huang F, Ding G, et al. Protective effects of fucoxanthin against alcoholic liver ınjury by activation of Nrf2- mediated antioxidant defense and ınhibition of Tlr4-mediated ınflamma- tion. Mar Drugs 2019;17:552.
  • 16. Özbeyli D, Kaya ÖT, Aydemir S, Aykaç A, Gürler EB, Yüksel M. The effect of beta glucan and fucoxanthine in a serulein ınduced acute pancre- atitis in rats. Bozok Med J 2020;10:189–97.
  • 17. Su J, Guo K, Huang M, Liu Y, Zhang J, Sun L, et al. Fucoxanthin, a ma- rine xanthophyll ısolated from Conticribra weissflogii Nd-8: Preventive anti-ınflammatory effect in a mouse model of sepsis. Front Pharmacol 2019;10:906.
  • 18. Yang YL, Lee MG, Lee CC, Su P, Chi C, Liu C, et al. Pentoxifylline de- creases post-operative intra-abdominal adhesion formation in an animal model. Peer J 2018;6:e5434.
  • 19. Ward A, Clissold SP. Pentoxifylline: A review of its pharmacodynam- ics and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987;34:50–97.
  • 20. Arslan S, Zeytun H, Basuguy E, Ibiloglu I, Uygun I, Yilmaz A, et al. Cordycepin prevents postoperative formation of intra-abdominal adhe- sion in a rat model: An experimental study. Ulus Travma Acil Cerrahi Derg 2017;23:273–8.
  • 21. Berkesoglu M, Karabulut YY, Yildirim DD, Turkmenoglu OM, Dirlik MM. Topical application of high-dose mesna prevents adhesion forma- tion: An experimental animal study. J Surg Res 2020;251:152–8.
  • 22. Casale M, Martino AD, Salvinelli F, Trombetta M, Denaro V. MESNA for chemically assisted tissue dissection. Expert Opin Investig Drugs 2010;19:699–707.
  • 23. Rasti M, Parvaresh E, Tavajoh S, Talaei M. The comparison of diphenhy- dramine HCL and nedocromil sodium in prevention of abdominal post- operative adhesion formation in rat models: An experimental study. Int J Surg 2007;5:384–7.
  • 24. Chaturvedi AA, Buyne OR, Lomme RM, Hendriks T, Van Goor H. Ef- ficacy and safety of ultrapure alginate-based anti-adhesion gel in experi- mental peritonitis. Surg Infect (Larchmt) 2015;16:410–4.
  • 25. Khorshidi HR, Kasraianfard A, Derakhshanfar A, Rahimi S, Shar- ifi A, Makarchian HR, et al. Evaluation of the effectiveness of sodium hyaluronate, sesame oil, honey, and silver nanoparticles in preventing postoperative surgical adhesion formation. An experimental study. Acta Cir Bras 2017;32:626–32.
  • 26. Attard JA, MacLean AR. Adhesive small bowel obstruction: Epidemiol- ogy, biology and prevention. Can J Surg 2007;50:291–300.
  • 27. Brochhausen C, Schmitt VH, Planck CN, Rajab TK, Hollemann D, Tapprich C, et al. Current strategies and future perspectives for ıntraperi- toneal adhesion prevention. J Gastrointest Surg 2012;16:1256–74.
  • 28. Song L, Li L, He T, Wang N, Yang S, Yang X, et al. Peritoneal adhesion prevention with a biodegradable and injectable N,O-carboxymethyl chi- tosan-aldehyde hyaluronic acid hydrogel in a rat repeated-injury model. Sci Rep 2016;6:37600.
APA DALBAŞI E, tüzün a, arserim n, ÖZCAN F, Dogan E, çetin a (2022). Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study. , 743 - 750. 10.14744/tjtes.2021.04134
Chicago DALBAŞI ERKAN,tüzün abidin,arserim neval berrin,ÖZCAN Filiz,Dogan Elif,çetin alpay Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study. (2022): 743 - 750. 10.14744/tjtes.2021.04134
MLA DALBAŞI ERKAN,tüzün abidin,arserim neval berrin,ÖZCAN Filiz,Dogan Elif,çetin alpay Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study. , 2022, ss.743 - 750. 10.14744/tjtes.2021.04134
AMA DALBAŞI E,tüzün a,arserim n,ÖZCAN F,Dogan E,çetin a Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study. . 2022; 743 - 750. 10.14744/tjtes.2021.04134
Vancouver DALBAŞI E,tüzün a,arserim n,ÖZCAN F,Dogan E,çetin a Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study. . 2022; 743 - 750. 10.14744/tjtes.2021.04134
IEEE DALBAŞI E,tüzün a,arserim n,ÖZCAN F,Dogan E,çetin a "Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study." , ss.743 - 750, 2022. 10.14744/tjtes.2021.04134
ISNAD DALBAŞI, ERKAN vd. "Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study". (2022), 743-750. https://doi.org/10.14744/tjtes.2021.04134
APA DALBAŞI E, tüzün a, arserim n, ÖZCAN F, Dogan E, çetin a (2022). Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study. Ulusal Travma ve Acil Cerrahi Dergisi, 28(6), 743 - 750. 10.14744/tjtes.2021.04134
Chicago DALBAŞI ERKAN,tüzün abidin,arserim neval berrin,ÖZCAN Filiz,Dogan Elif,çetin alpay Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study. Ulusal Travma ve Acil Cerrahi Dergisi 28, no.6 (2022): 743 - 750. 10.14744/tjtes.2021.04134
MLA DALBAŞI ERKAN,tüzün abidin,arserim neval berrin,ÖZCAN Filiz,Dogan Elif,çetin alpay Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study. Ulusal Travma ve Acil Cerrahi Dergisi, vol.28, no.6, 2022, ss.743 - 750. 10.14744/tjtes.2021.04134
AMA DALBAŞI E,tüzün a,arserim n,ÖZCAN F,Dogan E,çetin a Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study. Ulusal Travma ve Acil Cerrahi Dergisi. 2022; 28(6): 743 - 750. 10.14744/tjtes.2021.04134
Vancouver DALBAŞI E,tüzün a,arserim n,ÖZCAN F,Dogan E,çetin a Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study. Ulusal Travma ve Acil Cerrahi Dergisi. 2022; 28(6): 743 - 750. 10.14744/tjtes.2021.04134
IEEE DALBAŞI E,tüzün a,arserim n,ÖZCAN F,Dogan E,çetin a "Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study." Ulusal Travma ve Acil Cerrahi Dergisi, 28, ss.743 - 750, 2022. 10.14744/tjtes.2021.04134
ISNAD DALBAŞI, ERKAN vd. "Preventive effect of fucoxanthin administration on intra- abdominal adhesion: An experimental animal study". Ulusal Travma ve Acil Cerrahi Dergisi 28/6 (2022), 743-750. https://doi.org/10.14744/tjtes.2021.04134